Corvus Pharmaceuticals, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:CRVS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -8.26 M-5.78 M-9.57 M-9.19 M-10.37 M -34.91 M Cash from investing activities 4.24 M-20.3 M-2.62 M10.88 M-144.85 M -156.88 M Cash from financing activities 279 K35.77 M360 K20 K190.75 M 226.9 M Free cash flow -8.26 M-5.78 M-9.57 M-9.19 M-10.37 M -34.91 M

News

Corvus Pharmaceuticals, Inc. (CRVS) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow (NASDAQ:CRVS) 2026-06-05

Corvus Pharmaceuticals, Inc. (CRVS) Shareholder/Analyst Call Transcript

Stock Index Futures Gain on Hopes for U.S.-Iran Deal, Netflix Sinks on Disappointing Guidance

Corvus Pharmaceuticals Stock: Strong Clinical Narrative, Already Priced For Success (CRVS)

Cantor Fitzgerald reiterates Corvus Pharmaceuticals stock rating

Oppenheimer raises Corvus Pharmaceuticals stock price target to $33

Corvus Pharmaceuticals, Inc. (CRVS) Q4 2025 Earnings Call Transcript

Corvus Pharmaceuticals rises on atopic dermatitis trial data

Corvus Pharmaceuticals earnings on deck after positive trial data

Corvus earnings up next: Can pipeline buzz justify stock surge?

Corvus Pharmaceuticals, Inc. (CRVS) Discusses Phase 1 Clinical Trial Results of Soquelitinib in Atopic Dermatitis with Focus on Cohort 4 - Slideshow (NASDAQ:CRVS) 2026-01-27

Corvus Pharmaceuticals Stock Rallies 209% in a Month: Here's Why